Nomogram for Predicting Biliary Complication
Launched by SUN YAT-SEN UNIVERSITY · Oct 24, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial aims to create a tool called a nomogram to help predict the risk of biliary complications in adults who have received a liver transplant. Biliary complications are issues related to the bile ducts, which can occur within 90 days after surgery. The researchers will look at various factors, such as the patients' health before surgery and their experiences during and after the transplant, to determine what might contribute to these complications. By analyzing this data, they hope to improve how doctors can foresee and manage these risks for their patients.
To participate in this study, individuals must be at least 18 years old and have undergone their first liver transplant at Sun Yat-sen University First Affiliated Hospital between January 1, 2016, and December 31, 2021. Some people are not eligible, including those who received a liver from a living donor or had multiple organ transplants. Participants will not be recruited just yet, as the study is still in the planning phase. If you or a loved one qualifies and chooses to take part, you will be contributing to important research that could help improve care for future liver transplant patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ①Patients aged ≥ 18 years.
- • ②Patients who underwent their first liver transplantation at Sun Yat-sen University First Affiliated Hospital between January 1, 2016, and December 31, 2021.
- Exclusion Criteria:
- • Living donor liver transplantation. ② Split liver transplantation.
- • Multi-organ transplantation. ④ Missing preoperative baseline indicators and postoperative ultrasound examination results.
- • Patients undergoing re-transplantation.
About Sun Yat Sen University
Sun Yat-sen University, a prestigious institution located in Guangzhou, China, is dedicated to advancing medical research and healthcare innovations. As a leading clinical trial sponsor, the university leverages its extensive academic resources and collaboration with top-tier medical professionals to conduct rigorous clinical studies. Committed to improving patient outcomes and contributing to global health knowledge, Sun Yat-sen University focuses on a wide range of therapeutic areas, employing cutting-edge methodologies to ensure the integrity and efficacy of its research initiatives. Through its clinical trials, the university aims to foster scientific advancements and enhance the quality of care provided to patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported